scholarly journals Prenatal exposure to legacy contaminants and visual acuity in Canadian infants: a maternal-infant research on environmental chemicals study (MIREC-ID)

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
C. Polevoy ◽  
T. E. Arbuckle ◽  
Y. Oulhote ◽  
B. P. Lanphear ◽  
K. A. Cockell ◽  
...  
2020 ◽  
Vol 111 (3) ◽  
pp. 333-341 ◽  
Author(s):  
Janice M. Y. Hu ◽  
Tye E. Arbuckle ◽  
Patricia Janssen ◽  
Bruce P. Lanphear ◽  
Joseph M. Braun ◽  
...  

Chemosphere ◽  
2021 ◽  
Vol 264 ◽  
pp. 128402
Author(s):  
Anna O. Lukina ◽  
Mandy Fisher ◽  
Cheryl Khoury ◽  
John Than ◽  
Mireille Guay ◽  
...  

Author(s):  
Ye’elah E. Berman ◽  
Dorota A. Doherty ◽  
Katharina M. Main ◽  
Hanne Frederiksen ◽  
Martha Hickey ◽  
...  

Phthalates are ubiquitous environmental chemicals with endocrine disrupting properties and potentially obesogenic effects. We hypothesised that antenatal phthalate exposure may influence growth and adiposity patterns in girls through childhood into adolescence. Among 1342 Raine Study singleton females, 462 had maternal serum and at least one outcome available up to 20 years of age. Individuals’ maternal serum collected at 18 and 34 weeks gestation was pooled and analyzed for concentrations of 32 metabolites of 15 phthalate diesters. Cox regression and linear models were used to determine associations between maternal phthalate levels and age at menarche, change in height and weight z-scores between birth and two years, height from birth to 20 years, BMI from two to 20 years, deviation from mid-parental height at age 20 and DEXA scan measures at age 20. Weak negative associations were detected with some phthalate metabolites and change in height and weight z-score during infancy. Weak positive associations between some of the high molecular weight phthalate metabolites and height z-score were detected during childhood. While still within the normal range, age at menarche was slightly delayed in girls with higher prenatal exposure to the higher molecular weight phthalate metabolites. We derived some associations between prenatal phthalate exposure with early growth patterns and age at menarche.


2013 ◽  
Vol 27 (4) ◽  
pp. 415-425 ◽  
Author(s):  
Tye E. Arbuckle ◽  
William D. Fraser ◽  
Mandy Fisher ◽  
Karelyn Davis ◽  
Chun Lei Liang ◽  
...  

Author(s):  
Nina Lazarevic ◽  
Adrian G. Barnett ◽  
Peter D. Sly ◽  
Anna C. Callan ◽  
Ania Stasinska ◽  
...  

Author(s):  
Anderson J. Martino-Andrade ◽  
Shanna H. Swan

This chapter describes research on several commonly used analgesics that have been described as endocrine-disrupting chemicals, leading to concerns about possible interactions between therapeutic drugs and chemicals in the environment. Mild analgesics such as acetaminophen are widely used by pregnant women worldwide. In vitro, in vivo, and epidemiologic studies report that prenatal exposure to acetaminophen and other mild analgesics can cause hormonal disturbances resulting in gonadal development and male genital abnormalities, particularly cryptorchidism. These results suggest the potential for interaction between mild analgesics and environmental chemicals such as phthalates because they appear to disrupt similar hormonal signaling systems and cause common reproductive changes. Given the increased prevalence of prenatal exposure to phthalates and analgesics, these potential adverse effects should be taken into account when considering the risks and benefits of mild analgesic use during pregnancy.


Sign in / Sign up

Export Citation Format

Share Document